Legal & General Group PLC Novavax Inc Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Novavax Inc stock. As of the latest transaction made, Legal & General Group PLC holds 147,709 shares of NVAX stock, worth $1.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

147,709

Previous 112,631 31.14%

Holding current value

$1.96 Million

Previous $538,000 247.4%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $136,453 - $735,585	35,078 Added 31.14%	147,709 $1.87 Million
Q1 2024 Jul 01, 2024	BUY	$3.76 - $6.02 $24,455 - $39,154	6,504 Added 6.13%	112,631 $538,000
Q1 2024 May 14, 2024	BUY	$3.76 - $6.02 $25,500 - $40,827	6,782 Added 6.83%	106,127 $507,000
Q4 2023 Feb 15, 2024	BUY	$4.8 - $7.67 $12,753 - $20,379	2,657 Added 2.75%	99,345 $476,000
Q3 2023 Nov 14, 2023	SELL	$6.81 - $9.74 $62,495 - $89,383	-9,177 Reduced 8.67%	96,688 $700,000
Q2 2023 Aug 14, 2023	BUY	$6.67 - $9.52 $262,891 - $375,221	39,414 Added 59.31%	105,865 $786,000
Q1 2023 May 15, 2023	SELL	$5.76 - $12.48 $28,373 - $61,476	-4,926 Reduced 6.9%	66,451 $460,000
Q4 2022 Feb 14, 2023	SELL	$8.86 - $25.04 $27,306 - $77,173	-3,082 Reduced 4.14%	71,377 $733,000
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $131,258 - $548,977	-7,212 Reduced 8.83%	74,459 $1.36 Million
Q2 2022 Aug 22, 2022	SELL	$36.28 - $75.29 $5.74 Million - $11.9 Million	-158,083 Reduced 65.94%	81,671 $4.2 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $1.53 Million - $3.14 Million	21,947 Added 10.08%	239,754 $17.7 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $1.88 Million - $3.04 Million	-13,956 Reduced 6.02%	217,807 $31.2 Million
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $480,771 - $731,648	2,704 Added 1.18%	231,763 $48 Million
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $22.3 Million - $47.5 Million	184,500 Added 414.06%	229,059 $48.6 Million
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $450,564 - $1.28 Million	3,988 Added 9.83%	44,559 $8.08 Million
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $421,888 - $747,441	5,358 Added 15.22%	40,571 $4.53 Million
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $1.65 Million - $3.71 Million	20,767 Added 143.76%	35,213 $3.82 Million
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $123,949 - $747,724	8,943 Added 162.51%	14,446 $1.2 Million
Q1 2020 May 14, 2020	SELL	$3.93 - $16.0 $903 - $3,680	-230 Reduced 4.01%	5,503 $75,000
Q4 2019 Feb 13, 2020	SELL	$3.69 - $5.22 $1,523 - $2,155	-413 Reduced 6.72%	5,733 $23,000
Q3 2019 Nov 13, 2019	BUY	$4.02 - $7.84 $4,036 - $7,871	1,004 Added 19.53%	6,146 $31,000
Q2 2019 Aug 14, 2019	BUY	$4.93 - $12.2 $25,350 - $62,732	5,142 New	5,142 $32,000

Others Institutions Holding NVAX

# of Institutions

284

Shares Held

83.2M

Call Options Held

5.43M

Put Options Held

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $1.04B
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Novavax Inc Transaction History